GlassScriptPhysician profile
James Philip Hatfield
NPI 1255324612
$1,218.23
in general payments reported to CMS, 2019-2025
11 companies · $281 in 2025
The $281 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2021: $266 · 2022: $271 · 2024: $276 · 2025: $281.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $557.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $557.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $226.19 | 2019-2024 | Collagenase Santyl |
| Acumed LLC | $158.98 | 2025 | Acumed |
| Trimed, INC. | $125.00 | 2024 | |
| Boston Scientific Corporation | $124.91 | 2021 | |
| Horizon Therapeutics Plc | $124.51 | 2021 | |
| Amgen INC. | $121.84 | 2025 | Krystexxa |
| Musculoskeletal Transplant Foundation INC. | $104.62 | 2022 | |
| Orpyx Medical Technologies US INC. | $94.16 | 2022 | |
| Treace Medical Concepts, INC. | $71.99 | 2022 | |
| Elevate Surgical Co | $49.03 | 2024 | |
| Zimmer Biomet Holdings, INC. | $17.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Hatfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.